Notice

Easy Access IP: gamma-glutamyl transpeptidase (ggt) attenuated Francisella

This technology is Dstl-owned intellectual property available to organisations under the Easy Access IP scheme.

Document

Easy Access IP: gamma-glutamyl transpeptidase (ggt) attenuated Francisella

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email centralenquiries@dstl.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This technology relates to a mutated Francisella bacterium, wherein the ggt gene is silenced or deleted. The ggt gene is a well-characterised target, which should aid licensing of an attenuated Francisella vaccine.

You can read guidance for organisations on how to find out about and access Dstl-owned intellectual property available under the Easy Access IP scheme.

Published 5 February 2015